The lysine contingency treatment is a viral vector medication developed by Dr. Laura Sorkin and David Banks. It uses an adenovirus to deliver a genetic modification which eliminates InGen‘s lysine contingency.
The lysine contingency treatment is a viral vector medication developed by Dr. Laura Sorkin and David Banks. It uses an adenovirus to deliver a genetic modification which eliminates InGen‘s lysine contingency.